Skip to content
Screener

Guardian Pharmacy Services GRDN Q3 2025 earnings

Reported November 10, 2025 · After market close

Revenue$377.4MMiss by $12.6M
EPS$0.25Beat by $0.01
Revenue estimate$390.0M
EPS estimate$0.24

Next report

Date not yet announced

Financials

Q3 2025

Income statement

See full
Revenue$377.4M+20.0%
Gross profit$74.7M+22.7%
Operating income$16.4M+116%
Net income$9.8M+108%
EPS (diluted)$0.15+108%

Balance sheet

See full
Cash & equivalents$36.5M-2.0%
Total debt$34.1M-42.7%
Total assets$390.0M+12.1%

Cash flow

See full
Operating cash flow$28.2M—
CapEx$4.0M+80.5%
Free cash flow$24.2M—

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$1.66B—
Enterprise value$1.66B—
P/E58.7×—
P/S1.2×—

Profitability

See full
Gross margin19.7%-0.1pp
Net margin2%+1.1pp

Returns & leverage

See full
Current ratio1.2×+0.1×

Segments

By segment

See full
Corporate$377.4M+20.0%

FAQ

When did Guardian Pharmacy Services report Q3 2025 earnings?
Guardian Pharmacy Services (GRDN) reported Q3 2025 earnings on November 10, 2025 after market close.
What were Guardian Pharmacy Services's Q3 2025 revenue and EPS?
Guardian Pharmacy Services reported revenue of $377.4M and eps of $0.25 for Q3 2025.
Did Guardian Pharmacy Services beat estimates in Q3 2025?
Revenue missed the consensus estimate of $390.0M by $12.6M. EPS beat the consensus estimate of $0.24 by $0.01.
How did Guardian Pharmacy Services's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 20.0% from $314.4M a year earlier.
Where can I find Guardian Pharmacy Services's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-274250) and the 10-Q periodic report (0001193125-25-274298) directly on SEC EDGAR. The filing index links above go to sec.gov.